Exane Derivatives’s Expedia Group EXPE Stock Holding History

Exane Derivatives’s Portfolio EXPE Stock Details EXPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$284	Sell	3 -7,326	-100%	-$1.04M	﹤0.01%	645
2022 Q1	$1.43M	Buy	+7,329	New	+$1.37M	0.4%	54
2021 Q4	–	Sell	-1,146	Closed	-$188K	–	911
2021 Q3	$188K	Hold	1,146	–	–	0.05%	408
2021 Q2	$186K	Hold	1,146	–	–	0.04%	427
2021 Q1	$197K	Buy	1,146 +1,134	+9,450%	+$175K	0.06%	301
2020 Q4	$1.59K	Hold	12	–	–	﹤0.01%	646
2020 Q3	$1.1K	Hold	12	–	–	﹤0.01%	611
2020 Q2	$986	Hold	12	–	–	﹤0.01%	552
2020 Q1	$675	Sell	12 -2,319	-99%	-$223K	﹤0.01%	564
2019 Q4	$258K	Buy	2,331 +1,419	+156%	+$167K	0.05%	227
2019 Q3	$123K	Hold	912	–	–	0.02%	301
2019 Q2	$121K	Sell	912 -7,446	-89%	-$917K	0.02%	310
2019 Q1	$994K	Buy	+8,358	New	+$1.01M	0.2%	118

Other funds holding EXPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Exane Derivatives's EXPE Position: Q2 2022 in Review

Exane Derivatives reduced its Expedia Group (EXPE) stake by 100% in Q2 2022, selling an estimated $1.04M and leaving 3 shares worth $284. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Exane Derivatives first reported a position in EXPE in Q1 2019 and has held it in 13 quarters since. The position peaked at $1.43M in Q1 2022. 750 funds tracked by Wall St. Rank hold EXPE as of Q2 2022.

Exane Derivatives held 3 shares of Expedia Group worth $284 as of Q2 2022.
Exane Derivatives sold 7,326 Expedia Group shares in Q2 2022, an estimated $1.04M.
Expedia Group made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #645 holding.
Exane Derivatives first reported a position in Expedia Group in Q1 2019 and has held it in 13 quarters since.
Exane Derivatives's Expedia Group position peaked at $1.43M in Q1 2022.
750 funds tracked by Wall St. Rank held Expedia Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.